In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

AeroGen, BD develop inhalable insulin product

Executive Summary

Drug delivery company AeroGen and Becton Dickinson will combine technologies to co-develop an inhalable insulin product. AeroGen gets exclusive global rights and will find a marketing partner.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Pulmonary
      • Site Specific
Deal Status
  • Final
Deal Type
  • Alliance
    • R+D and Marketing-Licensing
    • Includes Contract
    • Includes Equity

Related Companies

Advertisement
UsernamePublicRestriction

Register